ticlopidine
发表于 2025-3-23 09:49:58
http://reply.papertrans.cn/29/2836/283565/283565_11.png
非实体
发表于 2025-3-23 16:54:45
Quantification of Dynamic Susceptibility Contrast T2* MRI in Oncology
克制
发表于 2025-3-23 21:03:52
http://reply.papertrans.cn/29/2836/283565/283565_13.png
过渡时期
发表于 2025-3-24 00:50:18
http://reply.papertrans.cn/29/2836/283565/283565_14.png
harpsichord
发表于 2025-3-24 02:32:09
http://reply.papertrans.cn/29/2836/283565/283565_15.png
染色体
发表于 2025-3-24 09:50:02
http://reply.papertrans.cn/29/2836/283565/283565_16.png
MURAL
发表于 2025-3-24 14:04:48
Dynamic Contrast-Enhanced MR Imaging for Predicting Tumor Control in Patients with Cervical Cancer
管理员
发表于 2025-3-24 17:53:41
http://reply.papertrans.cn/29/2836/283565/283565_18.png
爱管闲事
发表于 2025-3-24 20:00:45
Use of Dynamic Contrast-Enhanced MRI in Multi-Centre Trials with Particular Reference to Breast Canc
的事物
发表于 2025-3-25 01:37:09
Applications of Dynamic Contrast-Enhanced MRI in Oncology Drug Development